Our drugs engage the immune system to fight tumors
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
还没有评论，来抢沙发吧！
X 上关于 Eris Biotech 的真实讨论
去 X 发帖
